Modeling the Effects of Policy Changes on the Spread of Ebola New Mexico Final Report April 5, 2016 Team#: 112 Saturday Science and Math Academy Team

Similar documents
Genus Ebolavirus is 1 of 3 members of the Filoviridae family (filovirus), along with genus Marburgvirus and genus Cuevavirus.

Questions and Answers on Ebola

UTSW/BioTel EMS TRAINING BULLETIN October EMS TB Ebola Virus Disease (EVD)

12 June The average EVD case fatality rate has been around 50 per cent.

Media centre Ebola virus disease

EBOLA. Harford County Health Department October 22, 2014

Ebola Virus Patient Advisory

Ebola Virus Disease (EVD) Essential information

EBOLA VIRUS AWARENESS

Making Sense Of The Ebola Virus

saipem Ebola virus diseases EVD August 2014

Summary of current outbreak in Guinea, Liberia and Sierra Leone

Ebola Virus Disease. Global Epidemiology and Surveillance in Hong Kong. as of 13 August 2014

U.S. CDC s Response to the Ebola Outbreak

Ebola Virus Disease: the Facts, Response & the Way Forward. Dr. Abraham Idokoko Ebola Emergency Operations Centre (EEOC), Lagos.

Key Points Ebola Virus Disease, West Africa Newly updated information is indicated in red

The presenter has no potential or actual conflicts of interest and no relevant financial relationships to maters regarding or related to Ebola.

EBOLA FACTS. During this outbreak, most of the disease has spread through human-to-human transmission.

EDUCATIONAL COMMENTARY EMERGING INFECTIOUS DISEASES WITH GLOBAL IMPACT

Ebola. Wessex CPD Event 14/11/14. Dr Ishani Kar-Purkayastha, CCDC, Wessex PHE Centre Tel:

The Ebola Virus. By Emilio Saavedra

CIRCULAR LETTER No

Ebola Virus Disease. What the physician needs to know. (Overview, Transmission and Clinical Features)

EBOLA 101. Update for EMS System Stakeholders. Eric M. Rudnick, MD, FACEP, FAAEM Medical Director Nor Cal EMS Version 10/25/2014

Palliative Care in Ebola

News in Review December 2014 Teacher Resource Guide EBOLA: A Deadly Virus Outbreak

Grace Kubin, Ph.D. 10 th Annual Alabama Laboratory Meeting 2015

Confronting Ebola. Keeping NY patients and healthcare workers safe and healthy

EBOLA & OTHER VIRUSES IN THE NEWS EBOLA VIRUS, CHIKUNGUNYA VIRUS, & ENTEROVIRUS D68

Figure 1: Ebola Virus strengthens the framework for a scaled-up response.

Ebola Outbreak deadly infectious diseases as a potential major threat. Dilys Morgan

TRAVEL ADVISORY TO PREVENT THE IMPORTATION OF EBOLA INTO SOUTH AFRICA

Case study: Epidemic modelling in real life

An Outbreak of Hemorrhagic Fever in Africa

Information for Primary Care: Managing patients who require assessment for Ebola virus disease Updated 17 Oct 2014

U.S. and British troops head to West Africa to help fight Ebola virus

SHARE SELECTION. Click here to print. Thursday, Nov 6th AM 46 F 10AM 44 F 5 Day Forecast. By Associated Press

Ebola Epidemic in Coastal West Africa Overall Situation

EBOLA INFORMATION KIT 20 to 26 October 2014 MEMBERS NEWS HUNTING SERVICES FUND LEGISLATION CALENDAR GENERAL SHOP POPULAR ARTICLES

CDC Support for Exit Screening & Lessons Learned for Preparedness

Infectious Disease Outbreaks in confined spaces

PROFESSOR DAME SALLY C DAVIES CHIEF MEDICAL OFFICER CHIEF SCIENTIFIC ADVISER

Ebola Virus Diseases

CE Unit. Viruses and Vaccines

Ebola Virus Transmission

Epidemic Ebola Virus Disease Understanding, demystifying and controlling a frightening disease Republic of Guinea, 2014

TRAVEL ADVISORY TO PREVENT THE IMPORTATION OF EBOLA INTO SOUTH AFRICA

GOAL. Disclosure. Objectives 11/12/2014. Epi 101: Basic Epidemiological Definitions and Principles for Non-Epidemiologists

Ebola Exposure (Version )

SJCEMSC EBOLA VIRUS DISEASE RESPONSE GUIDELINE

Ebola: 22,000 cases, 8700 deaths. Enterovirus D68: 1100 cases, 14 deaths. Chikungunya virus: almost a million cases in the Western Hemisphere

EBOLA. Christina Liscynesky, MD Assistant Professor of Internal Medicine Division of Infectious Diseases Associate Medical Director of Epidemiology

Thank You to Our Partners. Law Enforcement Fire Services Emergency Management Public Health Behavioral/Mental Health

Distribution: As Appendix 1 Dr Ruth Hussey, Chief Medical Officer, Welsh Government Date: 10 October Ongoing Ebola outbreak in West Africa

Ebola Epidemic. The largest epidemic of Ebola virus disease (EVD) was experienced between December 2013

OUR COMMUNITY: OUR WORLD: ONE HEALTH. Ebola : Geomedicine Conference

Viral Hemorrhagic Fevers

Ebola Virus Disease: Occupational Safety and Health

WHAT S NEW WITH OSHA AND INFECTION CONTROL?

Communicating About Ebola: A Guide for Leaders. Produced by the Pan American Health Organization

1) Complete the Table: # with Flu

Public Health Perspectives: Coordination the Response to Imported Infectious Disease Threats in New York City

WHO SOUTHERN SUDAN HEALTH UPDATE May 2004

EMERGING INFECTIOUS DISEASES DISCLOSURES EMERGING NONE

Analysis on the Risk of Ebola

Ebola Virus Disease(EVD)

CDC Ebola Response Team

Create the Following Chart in your notebook. Fill in as you go through each one.

MARITIME AUTHORITY OF JAMAICA EBOLA VIRUS DISEASE TO: (I) (II) ALL MANAGERS AND OPERATORS OF JAMAICAN REGISTERED VESSELS (III)

Responding to the Potential of Ebola Virus Disease (EVD) Importation into Malaysia

Acute respiratory illness This is a disease that typically affects the airways in the nose and throat (the upper respiratory tract).

Fever virus going around 2017

Ebola Vaccines and Vaccination

Statements about Ebola: True or false? Part 1 Commented version for trainers only!

EBOLA VIRUS Guidance for Michigan local health departments and healthcare providers

MEEGID XII. Ebola viruses: from the wild to humans

Provider Health & Safety Alert Ebola Virus Disease September 30, 2014

CE Unit 7. Viruses and Vaccines

Digital Disease Detection: MERS, Ebola, and Measles. Maimuna S. Majumder

RAM U S. D E P A R T M E N T O F H E A L T H. E D U C A T IO N. AND W E LF A R E. J u l y 1970

Ebola. September 30, 2014 by Bill O'Grady, Kaisa Stucke of Confluence Investment Management

The Struggle with Infectious Disease. Lecture 5

UPDATE ON INFECTIOUS DISEASES 2015

Christina Liscynesky, MD

Disease dynamics: understanding the spread of diseases

PUBLIC HEALTH SIGNIFICANCE SEASONAL INFLUENZA AVIAN INFLUENZA SWINE INFLUENZA

COMPLETE ALL QUESTIONS AND MARGIN NOTES

EBOLA: A TEST OF THE DECISION ON SERIOUS CROSS-BORDER THREATS TO HEALTH Health Policy Forum 19 March Brussels

Epidemiology of Lassa Fever

Ebola Preparedness Protocols. Carole DuPerre, RN, BSN, CIC Maine Medical Center Department of Epidemiology and Infection Prevention May 14, 2014

A BSL-1 lab houses activities that require only standard microbial practices. These include:

PRESS STATEMENT ON MARBURG VIRUS DISEASE

Phylogenetic Tree Practical Problems

Treating the Spread of Malaria New Mexico Supercomputing Challenge Final Report April 4, Team 110 Saturday Science and Math Academy

EBOLA VIRUS DISEASE. Democratic Republic of Congo. External Situation Report 1. Credit : B.Sensasi / WHO Uganda-2007

Preventing the introduction of Ebola virus into the Eastern Mediterranean Region: enhanced preparedness is the key

Alemayehu Worku Arba Minch University, College of Agricultural Sciences, Department of Animal and Range Sciences

UNCLASSIFIED (Version 3, 25 Sep 2014)

EBOLA VIRUS DISEASE. Page 1

Information gaps in surveillance data and effects on the Ghanaian response to the Ebola outbreak in West Africa

Transcription:

Modeling the Effects of Policy Changes on the Spread of Ebola New Mexico Final Report April 5, 2016 Team#: 112 Saturday Science and Math Academy Team Members: Joaquín Madrid Larrañaga Malcolm Tatum Teachers: Debra Johns Project Mentor: Wayne Witzel

Contents Abstract 2 Introduction.3 Methods/Materials..4 Validation.6 Results...6 Conclusion...7 Acknowledgements..8 References...10 1

Abstract The 2014 Ebola outbreak was the worst Ebola outbreak ever recorded according to the World Health Organization. The Ebola Virus Disease (EVD) has mainly affected the West African populations. These countries include Guinea, Liberia, and Sierra Leone. There are five known strains of the Ebola virus all causing EVD. The particular strain researched in this project is the Zaire Ebolavirus (EBOV). EVD is spread by primates, infected fruit bats, by the consequential contact of bodily fluids, and contaminated needles or syringes. Once infected, symptoms include: fever, muscle pain, severe headache, weakness, diarrhea, abdominal pain, and unexplained bleeding or bruising. EVD is 90% fatal and for this reason has been detrimental to the citizens of West Africa. NetLogo, an agent based programming language was used to create different simulations modeling the spread of EVD throughout a population. A simulation modeling a generic virus was found in NetLogo s model library. This was adapted to simulate EVD as well as different policy changes preventing EVD. Four different models depicting different policy changes a country might put into place were created. The first is implementing travel restrictions on two populations. The second is applying contact tracing in conjunction with quarantine. The third is employing isolation and self-monitoring as well as quarantine. The fourth is modeling transportation between four different villages. The data from the second and third models show that overall quarantine is an effective method to slow the progression of the disease. However, quarantining suspected individuals without keeping them separate from infectious individuals does not help stop the spread of the disease. Quarantining in conjunction with self-monitoring is very effective. 2

Introduction The 2014 Ebola outbreak was the worst Ebola outbreak ever recorded, according to the World Health Organization. There are five known strains of the Ebola virus. These include: Zaire Ebolavirus (EBOV), Sudan Ebolavirus (SUDV), Tai Forest Ebolavirus (TAFV), Reston Ebolavirus (RESTV), and Bundibugyo Ebolavirus (BDBV). EBOV is the strain of Ebola being modeled in this project and is the most common in humans and other primates. EBOV causes the Ebola Virus Disease (EVD). EVD is a very harmful disease causing, fevers, vomiting, diarrhea, and hemorrhaging throughout the body. EVD is 90% fatal and for this reason has been detrimental to the citizens of West Africa. One of the first ways officials respond to an EVD outbreak is to isolate populations. They might do this in terms of quarantine or shutting down borders. Officials also put numerous travel restrictions into place. However, most of these restrictions are not perfect. Another way officials have helped stop the spread of EVD is through quarantine/ hospitalization. If a person is believed to have EVD they are asked to stay in isolation for 21 days to confirm their infection or are put into a quarantine zone. If a person is confirmed to have EVD a contact trace is then performed. Contact tracing is when officials figure out all the individual people the infected person has touched. Contact tracing can also include people who touched individuals the infected person touched. These people are then put into isolation to see if they have EVD. It is hypothesized that the highest measure of quarantine in conjunction with contact tracing, and the highest measure of travel restrictions will reduce the spread of the virus. 3

Methods/Materials Several EVD models have been created using NetLogo, an agent based programming language. The models show the spread of EVD throughout a contained space, modeling a community of 1000 people. This model takes into account the number of people in the simulation 1000, the infectiousness of the virus 23%, the chance of the host to recover 63%, and the duration of the virus 35 days. These variables are set to effectively model EVD. Once an individual comes in contact with an infectious individual there is a 23% chance they will become infected. Once a person is infected it takes 21 days for the individual to become infectious/show symptoms. The person is then infectious for an average of 30 days. After 30 days the individual either recovers or dies. There is a 63% chance an individual will recover. If the individual does recover, they will become immune to the virus. The model also simulates natural death in the population. Infected individuals are shown by the color red. Healthy individuals are shown by the color green. Immune individuals are shown by the color gray. In the first model two populations are created and are separated by a wall. This wall has a certain number of openings allowing individuals to cross into the other population. This model effectively models two different populations with a barrier between them. This could model two different villages, two countries, or two continents. In the second model, one person is infected to begin. When a healthy individual is touched by an infected person they turn yellow, modeling the contact tracing. When a yellow person touches a healthy person the healthy person turns purple. This furthers the concept of contact tracing. 4

Once a person is infected, they do not know whether they are infected or not. If they are infected they turn into a triangle for 21 days. After an infected individual has been infected for 21 days, they then become infectious. This is shown when an individual turns into a circle. However, for a period of five days, the person does not know they have EVD or is in denial. Once they know they have contracted EVD (after the five days) they turn red. During this time a certain percentage of the infected and suspected population will be sent to quarantine. Ten tests of each scenario were taken. The number of people killed by EVD was recorded each time. An average of the ten tests was taken. The standard deviation of the averages was calculated, as well as the standard deviation of the mean. The standard deviation is the range of probable deaths. The standard deviation of the mean is the range of error on the probable deaths. The third model has many of the same parameters as the second, in respect to the spread of EVD and contact tracing. However, instead of being sent to quarantine right away, the suspected individuals are sent to an isolated facility, usually their own home and told to selfmonitor for symptoms of EVD. For the purposes of this model, suspected individuals remain stationary until they develop symptoms, usually after 21 days. For the purposes of the model, stationary individuals have no chance to infect others while self-monitoring. Even though it might look like they touch others, for the purposes of the model they have no contact with others. In the fourth model, individuals are broken up into four different villages. As the individuals move around randomly they are inclined with some probability to stay close to their original village, however, some move away into other villages. This models the transportation of a virus over four villages. 5

Validation of the Model In order to create the most realistic model, several different sources were used. Extensive research was done to find the correct variables to make this project specific to EVD. An EVD expert, Sheldon Jordan, from UNM was consulted on the validity of variables specific to EVD such as the probability of infectiousness and the duration of recovery. Real events were examined to help make this model as realistic as possible. For example, the basis of the quarantine model was based on how African countries put patients in quarantine. The basis of the self-monitoring model was how the U.S.A. stopped the spread of EVD, which was through self-monitoring. The basis behind the village model was to show how a virus spreads through different villages, and how roads impacted this spread. Results 6

Conclusion One can conclude that any change in the porosity of the wall doesn t make a difference in the spread of the virus. This could be because once an infectious individual crosses the wall they are able to infect a large portion of the other population. This effectively defeats the purpose of 7

the wall. The only way the wall would be effective would be if individuals were not able to cross it at all. Overall, quarantine does reduce the amount of deaths in both quarantine models. However, in the first quarantine model, contact tracing did not reduce the spread of the virus. In fact, quarantining the first level of contact tracing (the yellow people) actually increased the amount of people dead. One reason this might be is because of the way the quarantine is set up. Once a suspected person is found a percent of them are set to quarantine. Since the quarantine region is so small, there is a high concentration of suspected individuals in one spot. However, not all suspected individuals are infected. After becoming infectious it takes five days for an individual to realize they have EVD. During this time infected individuals can infect suspected individuals. However, the standard deviation is pretty high, compromising some of the data. Quarantine, in combination with self-isolation and contact tracing does reduce the spread of EVD. This could be because the suspected people are in total isolation from the rest of the population. They have no contact with anyone. This prevents the spread of the disease. During the course of this project, several different predictive models were created. These models could be used to see how different policy changes are effective. These models could also be changed to model other viruses or bacterial infections. Acknowledgements This project would not be possible without the help and support of many people. First we would like to thank our mentor, Wayne Witzel from Sandia National Laboratories. We would also like to thank Debra Johns, who inspired us to create this project. We would also like to 8

acknowledge Sheldon Jordan for advising us specifically on the aspects of EVD. Most of all we would like to thank our families and friends for supporting all of our ideas. 9

Works Cited 1. Centers for Disease Control and Prevention. Centers for Disease Control and Prevention, 03 Feb. 2016. Web. 09 Feb. 2016. 2. "Ebola Virus." Opposing Viewpoints Online Collection. Detroit: Gale, 2015. Opposing Viewpoints in Context. Web. 9 Feb. 2016. 3. Goodman, Phillip. "Ebola Virus Strains. Types, Transmission and Mutation. Eniki Village, nod Web. 09 Feb. 2016. 4. Siettos, Constantinos, Cleo Anastassopoulou, Lucia Russo, Christos Grigoras, and Eleftherios Mylonakis. "Modeling the 2014 Ebola Virus Epidemic Agent-Based Simulations, Temporal Analysis and Future Predictions for Liberia and Sierra Leone. PLoS Currents. Public Library of Science, 9 Mar. 2015. Web. 09 Feb. 2016. 5. Stephens, David S., Bruce S. Ribner, Nancye R. Feistritzer, Monica M. Farley, Christian P. Larson, and John T. Fox. "Ebola Virus Disease: Experience and Decision Making for the First Patients outside of Africa. PLOS Medicine: N.p., 28 July 2015. Web. 09 Feb. 2016. 6. "WHO's Ebola Response." World Health Organization. N.p., n.d. Web. 20 Mar. 2016. 10